Oncobiologics is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products, services, research and therapies.
The company stated in the following document that they conduct pre-clinical trials of their drugs on animals.
“To make a final determination of biosimilarity or interchangeability, regulatory authorities may require additional confirmatory information beyond what we plan to initially submit in our applications for approval, such as more in-depth analytical characterization, animal testing or further clinical trials.” Read the following article
Oncobiologics, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, developing, manufacturing, and commercializing complex biosimilar therapeutics. It focuses on monoclonal antibodies, in the disease areas of immunology and oncology. [Source: MarketWatch]
Company Website: http://www.oncobiologics.com